TransMedics Group, Inc. logo
TransMedics Group, Inc. (TMDX)
Compare

TransMedics Group, Inc. (TMDX) Average Current Ratio

Current Ratio

The current current ratio for TransMedics Group, Inc. (TMDX) is N/A as of Saturday, June 20, 2026, shown against its trailing averages.

Average Current Ratio Chart

TMDX Current Ratio Averages

CURRENT RATIO CURRENT

N/A

CURRENT RATIO TTM

7.72

CURRENT RATIO 3Y

8.85

CURRENT RATIO 5Y

8.81

CURRENT RATIO 10Y

7.09

CURRENT RATIO 15Y

7.09

CURRENT RATIO 20Y

7.09

About TransMedics Group, Inc.

TransMedics Group, Inc. operates as a commercial-stage medical technology enterprise, committed to transforming the landscape of organ transplant therapy for patients worldwide grappling with end-stage organ failure. At the core of their offerings is the Organ Care System (OCS), an innovative, portable solution engineered to perfuse, optimize, and continuously monitor donor organs. This system leverages exclusive, tailored technology to meticulously recreate near-physiological conditions for these vital organs while they remain outside the human body. The OCS suite encompasses specialized modules: OCS LUNG, which facilitates the preservation of standard criteria donor lungs for double-lung transplants; OCS Heart, designed for the extracorporeal perfusion and maintenance of donor hearts; and OCS Liver, dedicated to the preservation of donor livers. Founded in 1998, TransMedics is headquartered in Andover, Massachusetts.

Andover, MA
728 employees
Healthcare / Medical - Devices
Sector
Healthcare
Industry
Medical - Devices
CEO
Waleed H. Hassanein